Erratum: Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: A [1H]MRS study (Translational Psychiatry (2014) 3 (e279) DOI:10.1038/tp.2013.53));Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: A [1H]MRS study

Translational Psychiatry

Volumn 3, Issue , 2013, Pages

  Horder, J ^a   Lavender, T ^a   Mendez, M A ^a   O'Gorman, R ^b   Daly, E ^a   Craig, M C ^a   Lythgoe, D J ^a   Barker, G J ^a   Murphy, D G ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Autism; Autism spectrum disorders; Glutamate; Glutamine; 1H MRS

Indexed keywords

CHOLINE; CREATINE; GLUTAMIC ACID; GLUTAMINE; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; AUTISM; BASAL GANGLION; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; MALE; METABOLITE; NEUROTRANSMISSION; PARIETAL CORTEX; PARIETAL LOBE; PHENOTYPE; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; SIGNAL TRANSDUCTION; SOCIAL EVOLUTION; ASPERGER SYNDROME; BRAIN LEVEL; CASE CONTROL STUDY; CHEMISTRY; CHILD; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SEVERITY OF ILLNESS INDEX;

ADULT; ASPERGER SYNDROME; AUTISTIC DISORDER; BASAL GANGLIA; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; FEMALE; GLUTAMIC ACID; GLUTAMINE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PREFRONTAL CORTEX; SEVERITY OF ILLNESS INDEX;

EID: 84880162430     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2014.7     Document Type: Erratum

References (43)

1. World Health Organization ICD-10 International Statistical Classification of Diseases and Related Health Problems. 10th edn WHO: Geneva, Switzerland, 1993.
2. Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE et al. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 2009; 194: 500-509.
3. Hallahan B, Daly EM, McAlonan G, Loth E, Toal F, O'Brien F et al. Brain morphometry volume in autistic spectrum disorder: a magnetic resonance imaging study of adults. Psychol Med 2009; 39: 337-346.
4. Barttfeld P, Wicker B, Cukier S, Navarta S, Lew S, Sigman M. A big-world network in ASD: dynamical connectivity analysis reflects a deficit in long-range connections and an excess of short-range connections. Neuropsychologia 2011; 49: 254-263.
5. Pizzarelli R, Cherubini E. Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast 2011; 2011: 297153.
6. Coghlan S, Horder J, Inkster B, Mendez MA, Murphy DG, Nutt DJ. GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev 2012; 36: 2044-2055.
7. Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J et al. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature 2010; 468: 263-269.
8. Gogolla N, Leblanc JJ, Quast KB, Sudhof T, Fagiolini M, Hensch TK. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J Neurodev Disord 2009; 1: 172-181.
9. Hussman JP, Chung RH, Griswold AJ, Jaworski JM, Salyakina D, Ma D et al. A noisereduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol Autism 2011; 2: 1.
10. Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B et al. Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 2002; 7: 302-310.
11. Jacob S, Brune CW, Badner JA, Ernstrom K, Courchesne E, Lord C et al. Family-based association testing of glutamate transporter genes in autism. Psychiatr Genet 2010; 21: 212-213.
12. Martin ER, Menold MM, Wolpert CM, Bass MP, Donnelly SL, Ravan SA et al. Analysis of linkage disequilibrium in gamma-aminobutyric acid receptor subunit genes in autistic disorder. Am J Med Genet 2000; 96: 43-48.
13. Dolen G, Bear MF. Fragile X syndrome and autism: from disease model to therapeutic targets. J Neurodev Disord 2009; 1: 133-140.
14. DeVito TJ, Drost DJ, Neufeld RW, Rajakumar N, Pavlosky W, Williamson P et al. Evidence for cortical dysfunction in autism: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry 2007; 61: 465-473.
15. Hardan AY, Minshew NJ, Melhem NM, Srihari S, Jo B, Bansal R et al. An MRI and proton spectroscopy study of the thalamus in children with autism. Psychiatry Res 2008; 163: 97-105.
16. Friedman SD, Shaw DW, Artru AA, Dawson G, Petropoulos H, Dager SR. Gray and white matter brain chemistry in young children with autism. Arch Gen Psychiatry 2006; 63: 786-794.
17. Harada M, Taki MM, Nose A, Kubo H, Mori K, Nishitani H et al. Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-Editing Proton MR Spectroscopy using a Clinical 3 Tesla Instrument. J Autism Dev Disord 2011; 41: 447-454.
18. Page LA, Daly E, Schmitz N, Simmons A, Toal F, Deeley Q et al. In vivo 1H-magnetic resonance spectroscopy study of amygdala-hippocampal and parietal regions in autism. Am J Psychiatry 2006; 163: 2189-2192.
19. Bernardi S, Anagnostou E, Shen J, Kolevzon A, Buxbaum JD, Hollander E et al. In vivo (1)H-magnetic resonance spectroscopy study of the attentional networks in autism. Brain Res 2011; 1380: 198-205.
20. Le Couteur A, Bailey A, Goode S, Pickles A, Robertson S, Gottesman I et al. A broader phenotype of autism: The clinical spectrum in twins. J Child Psychol Psychiatry 1996; 37: 785-801.
21. Geschwind DH, Levitt P. Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 2007; 17: 103-111.
22. Endo T, Shioiri T, Kitamura H, Kimura T, Endo S, Masuzawa N et al. Altered chemical metabolites in the amygdala-hippocampus region contribute to autistic symptoms of autism spectrum disorders. Biol Psychiatry 2007; 62: 1030-1037.
23. Haznedar MM, Buchsbaum MS, Hazlett EA, LiCalzi EM, Cartwright C, Hollander E. Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disorders. Am J Psychiatry 2006; 163: 1252-1263.
24. Schmitz N, Daly E, Murphy D. Frontal anatomy and reaction time in autism. Neurosci Lett 2007; 412: 12-17.
25. Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 2008; 13: 833-857.
26. Hollander E, Anagnostou E, Chaplin W, Esposito K, Haznedar MM, Licalzi E et al. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry 2005; 58: 226-232.
27. Alexander GE, DeLong MR, Strick PL. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357-381.
28. Kalbe E, Schlegel M, Sack AT, Nowak DA, Dafotakis M, Bangard C et al. Dissociating cognitive from affective theory of mind: a TMS study. Cortex 2010; 46: 769-780.
29. Murphy DG, Critchley HD, Schmitz N, McAlonan G, Van Amelsvoort T, Robertson D et al. Asperger syndrome: a proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 2002; 59: 885-891.
30. McAlonan GM, Cheung V, Cheung C, Suckling J, Lam GY, Tai KS et al. Mapping the brain in autism. A voxel-based MRI study of volumetric differences and intercorrelations in autism. Brain 2005; 128: 268-276.
31. Hampson DR, Adusei DC, Pacey LK. The neurochemical basis for the treatment of autism spectrum disorders and fragile X syndrome. Biochem Pharmacol 2011; 81: 1078-1086.
32. Yip J, Soghomonian JJ, Blatt GJ. Decreased GAD67 mRNA levels in cerebellar Purkinje cells in autism: pathophysiological implications. Acta Neuropathol 2007; 113: 559-568.
33. Yip J, Soghomonian JJ, Blatt GJ. Increased GAD67 mRNA expression in cerebellar interneurons in autism: implications for Purkinje cell dysfunction. J Neurosci Res 2008; 86: 525-530.
34. Benarroch EE. Serotonergic modulation of basal ganglia circuits: complexity and therapeutic opportunities. Neurology 2009; 73: 880-886.
35. Nakamura K, Sekine Y, Ouchi Y, Tsujii M, Yoshikawa E, Futatsubashi M et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch Gen Psychiatry 2010; 67: 59-68.
36. Makkonen I, Riikonen R, Kokki H, Airaksinen MM, Kuikka JT. Serotonin and dopamine transporter binding in children with autism determined by SPECT. Dev Med Child Neurol 2008; 50: 593-597.
37. Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S et al. Cortical serotonin 5- HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry 2006; 163: 934-936.
38. Girgis RR, Slifstein M, Xu X, Frankle WG, Anagnostou E, Wasserman S et al. The 5-HT(2A) receptor and serotonin transporter in Asperger's disorder: a PET study with [(11)C]MDL 100907 and [(11)C]DASB. Psychiatry Res 2011; 194: 230-234.
39. Goldberg J, Anderson GM, Zwaigenbaum L, Hall GB, Nahmias C, Thompson A et al. Cortical serotonin type-2 receptor density in parents of children with autism spectrum disorders. J Autism Dev Disord 2009; 39: 97-104.
40. Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J et al. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 1999; 45: 287-295.
41. Hazlett HC, Poe MD, Gerig G, Styner M, Chappell C, Smith RG et al. Early brain overgrowth in autism associated with an increase in cortical surface area before age 2 years. Arch Gen Psychiatry 2011; 68: 467-476.
42. Uchiyama HT, Saito DN, Tanabe HC, Harada T, Seki A, Ohno K et al. Distinction between the literal and intended meanings of sentences: a functional magnetic resonance imaging study of metaphor and sarcasm. Cortex 2011; 48: 563-583.
43. Smigielska-Kuzia J, Bockowski L, Sobaniec W, Kulak W, Sendrowski K. Amino acid metabolic processes in the temporal lobes assessed by proton magnetic resonance spectroscopy ((1)H MRS) in children with Down syndrome. Pharmacol Rep 2010; 62: 1070-1077.